This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          

Search results for "" (5834)

NHS unable to ‘secure full benefits’ of increased spending and staffing, says Government auditors
RSV routine vaccination for babies and older adults in the UK recommended by JCVI
Wine drinking associated with reduced risk of adverse cardiovascular outcomes
No link found between testosterone gel therapy and higher risk of cardiovascular events
Ceramide routine significantly reduces local adverse effects from topical acne therapy
Electronic prescribing system in ICU requires less pharmacist input to maintain patient safety
Perioperative pembrolizumab improves event-free survival in early-stage lung cancer
Review suggests biologics safe for pregnant women with psoriasis
Colchicine receives FDA approval for cardiovascular disease
Information about rare ciprofloxacin suicide link to be reviewed by MHRA
Almost 100,000 excess cardiovascular deaths in England since the start of the pandemic
Is topical roflumilast the rising star of dermatological treatments?
Do not suddenly stop taking antidepressants, patients warned after BBC programme
Patients with learning disabilities let down by poor links between primary and secondary care
Fresh calls for talks as NHS strike action risks becoming ‘business as usual’
Prehospital tranexamic acid offers no survival benefit for trauma-induced coagulopathy
Base-edited CAR7 T cells a potential treatment for relapsed T-cell leukaemia
Medical cannabis and the cardiovascular system: a dangerous combination?
Vorasidenib found to improve progression-free survival in IDH–mutant grade 2 gliomas
Apremilast benefits in psoriatic arthritis revealed by magnetic resonance imaging
ACS risk score tool fails to improve guideline use or adverse CV outcomes
Capnography machine learning model provides high diagnostic accuracy for COPD
Review suggests oseltamivir does not reduce risk of hospitalisation for influenza
Selinexor triple therapy improves survival in lenalidomide-refractory multiple myeloma
Hope for dystrophic epidermolysis bullosa sufferers after gene therapy approval
Lower intensity, shorter duration radiotherapy safe and effective for some breast cancer, says NICE
Current NHS will not survive the next decade, say two-thirds of junior doctors